These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 38529274)

  • 21. Survival of Colorectal Cancer in Patients With or Without Inflammatory Bowel Disease: A Meta-Analysis.
    Ou B; Zhao J; Guan S; Lu A
    Dig Dis Sci; 2016 Mar; 61(3):881-9. PubMed ID: 26518415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Age at diagnosis of inflammatory bowel disease influences early development of colorectal cancer in inflammatory bowel disease patients: a nationwide, long-term survey.
    Baars JE; Kuipers EJ; van Haastert M; Nicolaï JJ; Poen AC; van der Woude CJ
    J Gastroenterol; 2012 Dec; 47(12):1308-22. PubMed ID: 22627504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The actin-cytoskeleton pathway and its potential role in inflammatory bowel disease-associated human colorectal cancer.
    Kanaan Z; Qadan M; Eichenberger MR; Galandiuk S
    Genet Test Mol Biomarkers; 2010 Jun; 14(3):347-53. PubMed ID: 20406101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. KRAS and TP53 mutations in inflammatory bowel disease-associated colorectal cancer: a meta-analysis.
    Du L; Kim JJ; Shen J; Chen B; Dai N
    Oncotarget; 2017 Mar; 8(13):22175-22186. PubMed ID: 28077799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Colorectal cancer in inflammatory bowel disease: the risk, pathogenesis, prevention and diagnosis.
    Kim ER; Chang DK
    World J Gastroenterol; 2014 Aug; 20(29):9872-81. PubMed ID: 25110418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytokines, NF-kappaB, microenvironment, intestinal inflammation and cancer.
    Schottelius AJ; Dinter H
    Cancer Treat Res; 2006; 130():67-87. PubMed ID: 16610703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Temporal trend in inpatient mortality in inflammatory bowel disease-associated colorectal cancer vs non-inflammatory colorectal cancer: a nationwide retrospective study.
    Flores E; Mbachi C; Achebe I; Asotibe J; Palomera-Tejeda E; Vohra I; Udechukwu V; Kotwal V
    Int J Colorectal Dis; 2021 Apr; 36(4):701-708. PubMed ID: 33063223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular and cellular pathways in colorectal cancer: apoptosis, autophagy and inflammation as key players.
    Yu L; Zhang MM; Hou JG
    Scand J Gastroenterol; 2022 Nov; 57(11):1279-1290. PubMed ID: 35732586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of epigenetics in transformation of inflammation into colorectal cancer.
    Yang ZH; Dang YQ; Ji G
    World J Gastroenterol; 2019 Jun; 25(23):2863-2877. PubMed ID: 31249445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk?
    Dyson JK; Rutter MD
    World J Gastroenterol; 2012 Aug; 18(29):3839-48. PubMed ID: 22876036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Associations between single-nucleotide polymorphisms and inflammatory bowel disease-associated colorectal cancers in inflammatory bowel disease patients: a meta-analysis.
    Li H; Jin Z; Li X; Wu L; Jin J
    Clin Transl Oncol; 2017 Aug; 19(8):1018-1027. PubMed ID: 28243990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical expression of CDX2, β-catenin, and TP53 in inflammatory bowel disease-associated colorectal cancer.
    Laurent C; Svrcek M; Flejou JF; Chenard MP; Duclos B; Freund JN; Reimund JM
    Inflamm Bowel Dis; 2011 Jan; 17(1):232-40. PubMed ID: 20815042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Whole blood ACTB, B2M and GAPDH expression reflects activity of inflammatory bowel disease, advancement of colorectal cancer, and correlates with circulating inflammatory and angiogenic factors: Relevance for real-time quantitative PCR.
    Bednarz-Misa I; Neubauer K; Zacharska E; Kapturkiewicz B; Krzystek-Korpacka M
    Adv Clin Exp Med; 2020 May; 29(5):547-556. PubMed ID: 32424999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytokine- and chemokine-induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapy.
    Bhat AA; Nisar S; Singh M; Ashraf B; Masoodi T; Prasad CP; Sharma A; Maacha S; Karedath T; Hashem S; Yasin SB; Bagga P; Reddy R; Frennaux MP; Uddin S; Dhawan P; Haris M; Macha MA
    Cancer Commun (Lond); 2022 Aug; 42(8):689-715. PubMed ID: 35791509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interrelations of Apoptotic and Cellular Senescence Genes Methylation in Inflammatory Bowel Disease Subtypes and Colorectal Carcinoma in Egyptians Patients.
    Salama RH; Sayed ZEA; Ashmawy AM; Elsewify WA; Ezzat GM; Mahmoud MA; Alsanory AA; Alsanory TA
    Appl Biochem Biotechnol; 2019 Sep; 189(1):330-343. PubMed ID: 30989570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spatial transcriptomics atlas reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment components in colorectal cancer.
    Peng Z; Ye M; Ding H; Feng Z; Hu K
    J Transl Med; 2022 Jul; 20(1):302. PubMed ID: 35794563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colorectal cancer-inflammatory bowel disease nexus and felony of Escherichia coli.
    Khan AA; Khan Z; Malik A; Kalam MA; Cash P; Ashraf MT; Alshamsan A
    Life Sci; 2017 Jul; 180():60-67. PubMed ID: 28506682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intestinal immunomodulation. Role of regulative peptides and promising pharmacological activities.
    Motilva V; Talero E; Calvo JR; Villegas I; Alarcón-de-la-Lastra C; Sánchez-Fidalgo S
    Curr Pharm Des; 2008; 14(1):71-95. PubMed ID: 18220820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MYL9 expressed in cancer-associated fibroblasts regulate the immune microenvironment of colorectal cancer and promotes tumor progression in an autocrine manner.
    Deng S; Cheng D; Wang J; Gu J; Xue Y; Jiang Z; Qin L; Mao F; Cao Y; Cai K
    J Exp Clin Cancer Res; 2023 Nov; 42(1):294. PubMed ID: 37926835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.